The Ca 2؉ -activated fusion of secretory vesicles with the plasma membrane responsible for regulated neurotransmitter and hormone secretion has previously been studied in permeable neuroendocrine cells, where requirements for ATP and cytosolic proteins were identified. As reported here, Ca 2؉ -activated fusion mechanisms are also preserved following cell homogenization. The release of norepinephrine (NE) and other vesicle constituents from a PC12 cell membrane fraction was activated by micromolar Ca 2؉ (EC 50 ϳ 3 M) and exhibited a dependence upon MgATP and cytosol. Ca Cellular compartments within eukaryotic cells maintain discrete identities despite the continuous disassembly and reassembly required for the vectorial transport of lumenal and membrane proteins to specific destinations. This requires a molecular basis for membrane identity and strict regulation of the membrane fusion process (1). While recent progress toward understanding the molecular basis of vesicle targeting and fusion has been dramatic (2), the biochemical reactions responsible for membrane fusion remain poorly understood. Cell-free systems that reconstitute in vitro aspects of vesicle formation, translocation, targeting, and fusion have provided insights on the mechanisms of vesicle fission and fusion at several stages of the protein trafficking pathway (2).
The Ca 2؉ -activated fusion of secretory vesicles with the plasma membrane responsible for regulated neurotransmitter and hormone secretion has previously been studied in permeable neuroendocrine cells, where requirements for ATP and cytosolic proteins were identified. As reported here, Ca 2؉ -activated fusion mechanisms are also preserved following cell homogenization. The release of norepinephrine (NE) and other vesicle constituents from a PC12 cell membrane fraction was activated by micromolar Ca 2؉ (EC 50 ϳ 3 M) and exhibited a dependence upon MgATP and cytosol. Ca
2؉ -dependent NE release was inhibited by botulinum neurotoxins and by CAPS (Ca

2؉
-dependent activator protein for secretion) antibody implying that syntaxin, synaptobrevin, SNAP-25 (synaptosomal-associated protein of 25 kDa), and CAPS are required for regulated exocytosis in this system. The exocytosis-competent membrane fraction consisted of rapidly sedimenting dense core vesicles associated with plasma membrane fragments. Free vesicles did not release NE either in the absence or presence of plasma membranes, indicating that only docked vesicles were competent for exocytosis under the reconstitution conditions used. A cell-free system for Ca 2؉ -activated fusion will facilitate studies on the roles of essential proteins such as syntaxin, synaptobrevin, SNAP-25, and CAPS that act at post-docking steps in the regulated exocytotic pathway.
Cellular compartments within eukaryotic cells maintain discrete identities despite the continuous disassembly and reassembly required for the vectorial transport of lumenal and membrane proteins to specific destinations. This requires a molecular basis for membrane identity and strict regulation of the membrane fusion process (1) . While recent progress toward understanding the molecular basis of vesicle targeting and fusion has been dramatic (2), the biochemical reactions responsible for membrane fusion remain poorly understood. Cell-free systems that reconstitute in vitro aspects of vesicle formation, translocation, targeting, and fusion have provided insights on the mechanisms of vesicle fission and fusion at several stages of the protein trafficking pathway (2) .
A tightly regulated membrane fusion process underlies the secretion of peptide hormones and neurotransmitters from endocrine and neural cells. Exocytotic fusion of secretory vesicles with the plasma membrane is triggered by intracellular Ca 2ϩ concentration increases into the 1-300 M range (3) . Recent studies have identified some of the proteins required for regulated fusion (see "Discussion"), but an understanding of the events in which these proteins participate and their relationship to membrane bilayer fusion remains limited due to the lack of functional cell-free in vitro assays for Ca 2ϩ -regulated fusion.
Studies of regulated fusion have instead utilized permeable cell preparations, most of which exhibit limited permeability or possess limited stability. Exceptions where exocytotic fusion reactions have been studied in vitro in cell-free systems are reconstituted sea urchin egg cortices (4) and acinar pancreatic zymogen granule-plasma membrane preparations (5); however, these systems exhibit a poorly understood partial or complete loss of Ca 2ϩ regulation. An extension of previous studies (6, 7) of Ca 2ϩ -activated exocytosis in mechanically permeabilized PC12 neuroendocrine cells led to the development of a simple purified membrane preparation consisting of large dense core vesicles (LDCVs) 1 associated with plasma membrane fragments. This preparation may be enriched for a very late stage intermediate of the regulated exocytotic pathway in which LDCVs are stably docked at the plasma membrane and in which the final steps of Ca 2ϩ -regulated fusion can be studied in vitro.
MATERIALS AND METHODS
Cell Culture and Labeling-PC12 cells were cultured in 10-cm dishes as described previously (8) Cell Homogenization and Sucrose Gradients-Cell homogenates were prepared by passing cell suspensions 15 times through a narrow clearance (10 m) stainless steel ball homogenizer (9) . Homogenates were clarified by centrifugation at 800 ϫ g for 10 min twice in succession to rigorously remove broken cells (monitored microscopically), and the postnuclear supernatant was centrifuged at 5000 ϫ g for 10 min to recover rapidly sedimenting LDCVs. The 5000 ϫ g membrane pellet was washed by resuspension in Kglu buffer and centrifugation at 10,000 ϫ g for 10 min. Approximately 28% of the [ 3 H]NE in post-nuclear supernatants was rapidly sedimenting and recovered in 5000 ϫ g pellets. The remaining free LDCVs were quantitatively isolated from a 10,000 ϫ g supernatant by centrifugation at 40,000 ϫ g for 15 min. * This work was supported by United States Public Health Service Grants DK25861 and DK40428 (to T. F. J. M.).The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
‡ To whom correspondence should be addressed: Whereas the majority of synaptic vesicle-like microvesicles containing synaptophysin was present in the supernatant of the 40,000 ϫ g centrifugation, LDCVs in PC12 cells also contain synaptophysin (see Fig.  2 ). For sucrose gradient purification, 5000 ϫ g pellet fractions were collected on a pad of 2 M sucrose in 0.02 M Tris, pH 7.8, 0.15 M NaCl, 0.002 M EGTA (TNE buffer), diluted 5-fold, and loaded onto either continuous or discontinuous sucrose gradients. Continuous gradients consisting of 9 ml of a linear gradient of 0.25-2 M sucrose and discontinuous gradients consisting of 2 ml each of 0.25, 0.5, 1.0, 1.5, and 2 M sucrose in TNE were centrifuged in a Beckman SW 41 rotor at 20,000 ϫ g for 30 min and collected from the bottom. For Western blotting, membranes were recovered from gradient fractions by 8-fold dilution in TNE buffer and centrifugation at 150,000 ϫ g for 16 h. Pellets were solubilized in sample buffer for electrophoresis on SDS-polyacrylamide gels and transferred to nitrocellulose for immunoblotting with antibodies to chromogranin B (Pel-Freez, Rogers, AR), synaptophysin (Boehringer Mannheim), SV2 (R.H. Scheller, Stanford), syntaxin (Sigma), and SNAP-25 (Sternberger Monoclonals Inc., Baltimore, MD). Rabbit polyclonal antibodies to synaptotagmin I were generated using a glutathione S-transferase-cytoplasmic domain fusion protein of synaptotagmin I. Rabbit polyclonal antibodies to synaptobrevin-2 were generated using an N-terminal peptide (SATAATVPPAAPAGEGGPPC) conjugated to bovine serum albumin. Western blots were processed with 125 I-protein A or 125 I-labeled goat anti-mouse antibody (DuPont NEN) and subjected to autoradiography.
Exocytosis Assays-Secretion assays to monitor the release of [ 3 H]NE were conducted in 0.2-ml reactions that contained Kglu buffer adjusted with CaCl 2 to the indicated [Ca 2ϩ ] f , 0.002 M MgCl 2 , 0.002 M ATP, and the resuspended 5000 ϫ g pellet. Incubations at 30°C were terminated by chilling on ice, followed by centrifugation at 100,000 ϫ g for 90 min. 
RESULTS
Regulated Exocytosis in PC12 Cell
Homogenates-The Ca 2ϩ -regulated secretion of NE is faithfully reconstituted in PC12 cells permeabilized by single passage through a narrow clearance ball homogenizer (6, 7). The Ca 2ϩ -dependent release of NE and other vesicle constituents by exocytotic fusion of LDCVs with the plasma membrane is ATP-and cytosol proteindependent and inhibited by clostridial neurotoxins that specifically proteolyze synaptobrevin, SNAP-25, and syntaxin (6 -10) . Multiple passes of PC12 cells through a wider clearance ball homogenizer generated a cell homogenate consisting of small membrane fragments and intact LDCVs. Surprisingly, ATP-and cytosol-dependent, Ca 2ϩ -activated release of NE was preserved in membranes recovered from the homogenate (Fig.  1A) . The Ca 2ϩ -dependent release of NE was not affected by dilution of the membranes, suggesting that the responsive subcellular fraction contained all of the membranes that participate in exocytotic fusion. The responsive fraction was recovered by centrifugation at 5000 ϫ g and was found to contain ϳ28% (12-44%, n ϭ 8) of the cellular LDCVs present in post-nuclear supernatants based on the recovery of [ 3 H]NE or vesicle-specific antigens (see below). Free LDCVs in the homogenate fail to sediment at 5000 ϫ g but are fully recovered by centrifugation at 40,000 ϫ g consistent with the size (ϳ75 nm) of LDCVs in PC12 cells (11) . Comparison of the membranes sedimented at 5000 ϫ g and 40,000 ϫ g showed that only the former exhibited Ca 2ϩ -activated NE release (Fig. 1B) , indicating that free LDCVs do not release their contents under standard incubation conditions. Because the LDCVs in the 5000 ϫ g pellet fraction exhibited Ca 2ϩ -dependent NE release and sedimented more rapidly than free LDCVs, it was likely that these LDCVs were associated with plasma membranes.
Regulated Exocytosis in a LDCV-Plasma Membrane Complex-To characterize the membranes present in the 5000 ϫ g pellet fraction, analysis by velocity gradient centrifugation was conducted (Fig. 2) . LDCVs in the 5000 ϫ g pellet fraction sedimented rapidly into the gradient ( Fig. 2A, arrow) as indicated by the co-sedimentation of LDCV contents markers [ 3 H]NE, chromogranin B ( Fig. 2A) , and dopamine ␤-hydroxylase (data not shown). The vesicle membrane proteins synaptotagmin I, synaptophysin (Fig. 2, A and B) , SV2, and synaptobrevin (data not shown) co-sedimented with the contents markers. Rapidly sedimenting LDCVs also exhibited reserpinesensitive amine transporter activity characteristic of NE-containing LDCVs (Fig. 2C) . Variable amounts of LDCVs were dislodged during preparation and sedimented nearer the top of the gradients at a position characteristic of free LDCVs (e.g. fraction 12 in Fig. 2A) . Incubation of the 5000 ϫ g pellet fraction under exocytosis conditions prior to gradient analysis revealed that the release of NE occurred from the rapidly FIG. 1. Ca 2؉ -activated NE release from membrane fractions of a PC12 cell homogenate. [ 3 H]NE-labeled PC12 cells were homogenized by 15 passes through a ball homogenizer. A, membranes collected at 15,000 ϫ g and 40,000 ϫ g were resuspended in Kglu buffer, pooled and incubated at 30°C for 10 min in the absence (E) or presence (q) of 10 M Ca 2ϩ , 2 mM MgATP, and 0.5 mg/ml cytosol. A fixed aliquot of membranes was incubated in the indicated volumes that varied 8-fold. B, membranes from post-nuclear supernatants were collected by sequential centrifugation at 5000 ϫ g and 40,000 ϫ g. Pellets were resuspended separately and incubated for the indicated times at 30°C in Kglu buffer (E), buffer supplemented with 3 M MgGMPPNP (å), or Ca 2ϩ , MgATP, and cytosol (q).
Cell-free Ca 2ϩ
-activated Exocytosissedimenting but not free LDCVs (Fig. 2D) .
Plasma membranes were monitored by surface labeling of cells and by immunoblotting with SNAP-25 and syntaxin antibodies. The majority of plasma membrane in the PC12 cell homogenate sedimented at 800 ϫ g. About 23% of the plasma membrane was recovered in the 5000 ϫ g pellet fraction and the majority of this co-sedimented with LDCVs in sucrose gradients (Fig. 2, B and E, arrow) . Co-sedimentation of LDCVs and plasma membranes was also observed in isopycnic gradient centrifugation in sucrose, Percoll and Ficoll (data not shown). Incubation of 5000 ϫ g pellet fractions under exocytosis conditions prior to gradient analysis revealed a redistribution of plasma membranes following membrane fusion (Fig.  2E) . Collectively, the results indicated that the rapidly sedimenting, exocytosis-competent subcellular fraction consisted of LDCVs associated with plasma membrane fragments.
Electron microscopy of the membrane complex purified on sucrose gradients was consistent with this conclusion revealing the presence of LDCVs on membrane fragments (Fig. 3, left  panel) . LDCVs were not evident in membrane fractions that were incubated with Ca 2ϩ in the presence of ATP and cytosol (Fig. 3, right panel) as anticipated if exocytotic fusion and the release of LDCV constituents had occurred.
The majority of LDCVs in PC12 cells are morphologically docked at the plasma membrane (12) , but only about one-third of the LDCVs in a post-nuclear supernatant fraction were isolated in a homogenization-resistant complex with plasma membranes. To evaluate the possibility that LDCV-plasma membrane complexes were disrupted during homogenization, the conditions of homogenization were systematically varied. The results (data not shown) indicated that an optimal yield of rapidly sedimenting LDCVs required 5-10 passes through the , largely dependent on cytosol, and partially dependent on MgATP (Fig. 4A) . Ca 2ϩ activation was half-maximal at 2-5 M and optimal at 10 M (Fig. 4B) . Ca 2ϩ stimulated the concomitant release of several LDCV constituents in addition to NE including preloaded quinacrine (Fig. 4C ) and chromogranin B (Fig. 4D) . The Ca 2ϩ -activated release of LDCV constituents was entirely abolished by treatment with type B, type C (data not shown), and type E (Fig. 4E) botulinum neurotoxins, indicating a requirement for functional synaptobrevin, syntaxin, and SNAP-25 as anticipated for Ca 2ϩ -dependent exocytotic fusion (13) . Botulinum neurotoxin-sensitive release of NE from LDCV-plasma membrane preparations was alternatively activated by nonhydrolyzable GTP analogs such as GMPPNP in the absence of Ca 2ϩ (Fig. 1B) , although the rate of stimulated secretion was lower than with Ca 2ϩ even at maximally effective concentrations (3 M) of MgGMPPNP.
Previous studies with permeable PC12 cells had shown that the requirement for MgATP in regulated exocytosis was for priming steps that precede the final step of Ca 2ϩ -triggered fusion (7). The MgATP requirement for NE release from LDCVplasma membrane preparations was similarly found to be largely met in preincubations with MgATP lacking Ca 2ϩ (Fig.  5 ), indicating that a priming process was required for optimal exocytosis of docked LDCVs. In permeable cells, the Ca 2ϩ -triggered fusion step that follows priming was shown to require a 145-kDa cytosolic protein CAPS (6, 7).
2 CAPS was also found to be necessary for Ca 2ϩ -triggered fusion in the LDCV-plasma membrane preparation, as indicated by the specific inhibition observed with IgGs from CAPS immune serum but not control IgGs (Fig. 4A) . A nearly complete (90%) inhibition of cytosoldependent NE release was observed in incubations with a different CAPS antibody (data not shown), indicating that the incomplete inhibition shown in Fig. 4A (Fig. 6 ). Similar studies with GMPPNP to trigger fusion at low Ca 2ϩ concentrations also failed to provide evidence for fusion of free LDCVs with the plasma membrane (data not shown). The results indicated that exocytosis was restricted to LDCVs already docked at the plasma membrane and that LDCV recruitment to and functional docking at the plasma membrane was not reconstituted in the standard exocytosis assay.
DISCUSSION
Elucidation of the process of Ca 2ϩ -regulated membrane fusion will require identification of proteins that mediate secretory vesicle transport to, docking at, and fusion with the plasma membrane as well as those that mediate the Ca 2ϩ regulation of steps in this sequence. Some of the proteins required for regulated exocytosis have recently been identified, but their precise roles are poorly understood. The SNARE proteins (for soluble NSF attachment protein receptors) synaptobrevin, syntaxin, and SNAP-25, which are the targets of clostridial neurotoxin proteolytic activity (14) and the receptors for the NSF/SNAP proteins required for constitutive fusion (2, 15), form oligomeric complexes that are proposed to function in vesicle docking and/or fusion (2, 16) . Studies on the Ca 2ϩ -binding vesicle protein synaptotagmin suggest its possible role as a Ca 2ϩ -dependent regulator of exocytosis (13) . Many additional proteins potentially involved in regulated secretion have been identified genetically or biochemically but remain poorly understood (13, 17) . Physiological studies in neuroendocrine cells indicate that secretory granules are staged at numerous points in the exocytotic pathway in transit to the plasma membrane for fusion (18) and that Ca 2ϩ accelerates granule transit through several stages that include recruitment to the plasma membrane for docking, post-docking priming steps, fusion pore formation, and fusion pore expansion (17) . It will be essential to 
Cell-free Ca 2ϩ
-activated Exocytosisreconstitute these stages along the exocytotic route in vitro as distinct biochemical steps in which the role of specific proteins can be assessed and their mechanisms determined.
Some progress toward elucidating partial reactions in the exocytotic pathway has been achieved with permeable neuroendocrine cells. In permeable PC12 cells where the majority of LDCVs are morphologically docked, ATP-dependent priming steps precede and are required for Ca 2ϩ -activated fusion steps (7, 12) . Ca 2ϩ -activated secretion in LDCV-plasma membrane preparations similarly exhibited a requirement for ATP. Because the LDCVs are stably docked at the plasma membrane, the results indicate that priming is distinct from vesicle recruitment or docking and that it occurs in vitro following docking and prior to fusion.
Two distinct ATP-dependent priming reactions have been characterized in permeable PC12 cells. In the first of these, PI transfer protein and phosphoinositide kinases catalyze synthesis of PI(4,5)P 2 , which is required for Ca 2ϩ -triggered fusion (19, 20) . In a second priming process, NSF and SNAP proteins catalyze a rearrangement of SNARE protein complexes (12) . It remains to be determined whether both of these priming reactions are required for exocytosis in the LDCV-plasma membrane preparation or whether the stably docked LDCVs are at a stage beyond one of these priming steps. The one third of the 3 H]NE-labeled PC12 cells were incubated at 30°C for 10 min in the presence of 10 M Ca 2ϩ , 2 mM MgATP, 0.5 mg/ml cytosol, 2 mg/ml rabbit IgG (IgG), or 2 mg/ml IgG purified from CAPS antiserum (␣CAPS) as indicated. B, incubations were conducted at 2 mM MgATP in the indicated Ca 2ϩ concentrations in the absence (E) or presence (q) of cytosol. C, PC12 cells were incubated with 10 M quinacrine for 60 min prior to preparation of 5000 ϫ g pellet fractions. Incubations similar to those in B were conducted with 2 mM MgATP in the absence or presence of 10 M Ca 2ϩ and cytosol as indicated. Membranes were pelleted, and the fluorescence of supernatants was measured (Ex ϭ 424 nm; Em ϭ 505 nm). D, incubations were conducted as in C with 5000 ϫ g pellet fractions from unlabeled PC12 cells, and the supernatants following centrifugation were analyzed by immunoblotting with chromogranin B antibodies. E, incubations were conducted as in A with Ca 2ϩ , MgATP, and cytosol following a 3-min incubation at 30°C with indicated concentrations of the botulinum neurotoxin E light chain (BoNT).
Cell-free Ca 2ϩ -activated Exocytosis
LDCVs that are consistently recovered in rapidly sedimenting complexes represent a subset of morphologically docked LDCVs that are in a stable, homogenization-resistant state of association with the plasma membrane. It is possible that this unusually stable docked state represents a late prefusion intermediate in which LDCVs intimately associate with the plasma membrane prior to fusion. This intermediate might result from a specific late post-docking reaction, possibly one of the ATPdependent priming steps, having been completed in situ prior to homogenization. It will be important to determine the molecular basis for the stable association of LDCVs with the plasma membrane. This stable association might be maintained by protein-protein interactions such as those among the SNARE proteins (16, 21) , by protein-membrane interactions as proposed for synaptotagmin and phospholipids (22) , or by partial membrane fusion as proposed for a stalk intermediate in a hemi-fusion mechanism (23) .
A related issue concerns the mechanisms responsible for LDCV docking at the plasma membrane. Under standard incubation conditions, free LDCVs were unable to engage in fusion with the plasma membrane. This may be due to saturation of plasma membrane docking sites by the stably bound LDCVs, to the absence of critical factors required for docking, or to the presence of barriers to docking such as cytoskeletal elements. MacLean and Edwards (5) reported that zymogen granules and pancreatic plasma membranes apparently engage in docking that is followed by fusion. However, fusion in that preparation was not activated by Ca 2ϩ but by nonhydrolyzable guanine nucleotides. Because GTP analogs elicit NE release by a Ca 2ϩ -independent, botulinum neurotoxin-sensitive mechanism in the LDCV-plasma membrane preparation, GMPPNP was also tested in mixed incubations of LDCVs with LDCV-plasma membrane complexes, but fusion was not detected. Hence, the process of functional LDCV docking was not reconstituted under the present incubation conditions and will need further investigation.
Studies with permeable PC12 cells indicated that the late Ca 2ϩ -dependent step beyond docking and ATP-dependent priming is sensitive to inhibition by clostridial neurotoxins, implying roles for SNARE proteins proximal to Ca 2ϩ -dependent membrane fusion steps (11) . Studies in other systems have suggested a post-docking role for SNARE proteins (14, 18, 25, 26) . The present results further confirm that SNARE proteins have a function beyond docking because Ca 2ϩ -activated fusion in the LDCV-plasma membrane preparation was completely inhibited by neurotoxins that proteolytically cleave synaptobrevin, syntaxin, and SNAP-25. Because SNARE proteins in hetero-oligomeric complexes are insensitive to neurotoxin proteolysis (27), the inhibition of regulated secretion in LDCVplasma membrane preparations by neurotoxins implies that the SNARE proteins are beyond the point of oligomerization that confers toxin-insensitivity. Studies in permeable PC12 cells showed that SNARE proteins become accessible to neurotoxin proteolysis following the NSF-catalyzed rearrangement that occurs during priming (13) . It will be of interest to determine whether NSF-dependent priming events occur in the LDCV-plasma membrane preparation in vitro or whether they were completed in situ prior to the isolation of the stably docked LDCVs.
Previous studies in permeable PC12 cells revealed a requirement for the 145-kDa CAPS protein in Ca 2ϩ -activated LDCV fusion at a step beyond docking and priming (7) . 2 Similarly, a requirement for CAPS for regulated fusion in the LDCVplasma membrane preparation was shown by specific antibody inhibition confirming a role for CAPS beyond docking. Recent studies have shown that CAPS is a PI(4,5)P 2 -binding protein consistent with a role beyond priming during which PI(4,5)P 2 synthesis occurs. 3 While regulated exocytosis in the LDCVplasma membrane preparation exhibits some of the same properties as that in permeable cells, this preparation provides simplifications over permeable cells in consisting of a structurally less complex, exocytosis-competent fraction that will facil- 
itate mechanistic studies on the roles of specific proteins at a post-docking step in the exocytotic pathway.
